ImmunoGen, Inc. IMGN

Set alert

Price alert · IMGN

All alert types
31.24 0.00 0.00%

As of Feb 9, 3:58 PM ET

31.22 Day range 31.25

52-week range unavailable

Open
31.24
Prev close
31.24
Mkt cap
8.72B
Vol
19.31M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
31.22
High
31.25
Forward P/E
86.75
Beta
1.17
Short ratio
3.78
Inst. own
86.52%
Dividend
0.00
Ex-div date
Earnings
Mar 6, 2024
50-d avg
29.71
200-d avg
19.72
1y target
25.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for IMGN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

18.14 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5.6×
FY 2013: -14.3×FY 2014: -20.3×FY 2015: -1.9×FY 2016: -1.1×FY 2017: -6.5×FY 2018: -4.0×FY 2019: -6.2×FY 2020: -17.0×FY 2021: -6.9×FY 2022: -5.6×
FY 2013 5y median -6.2× FY 2022
P/S 11.6×
FY 2013: 16.9×FY 2014: 14.5×FY 2015: 4.5×FY 2016: 3.7×FY 2017: 5.4×FY 2018: 12.5×FY 2019: 9.2×FY 2020: 8.6×FY 2021: 21.9×FY 2022: 11.6×
FY 2013 5y median 11.6× FY 2022
P/B 8.1×
FY 2013: 13.4×FY 2014: 35.2×FY 2015: -3.3×FY 2016: -1.2×FY 2017: -35.1×FY 2018: 56.3×FY 2019: -10.0×FY 2020: 12.7×FY 2021: 4.7×FY 2022: 8.1×
FY 2013 5y median 8.1× FY 2022
P/FCF -5.4×
FY 2013: -16.4×FY 2014: -19.7×FY 2015: -2.0×FY 2016: -1.2×FY 2017: 96.3×FY 2018: -3.9×FY 2019: -8.3×FY 2020: -14.3×FY 2021: -6.6×FY 2022: -5.4×
FY 2013 5y median -6.6× FY 2022
EV/EBITDA -4.6×
FY 2013: -12.2×FY 2014: -17.3×FY 2015: -1.0×FY 2016: -0.1×FY 2017: -6.5×FY 2018: -2.7×FY 2019: -7.3×FY 2020: 327×FY 2021: -8.0×FY 2022: -4.6×
FY 2013 5y median -4.6× FY 2022
EV/Sales 9.2×
FY 2013: 14.5×FY 2014: 11.2×FY 2015: 2.0×FY 2016: 0.4×FY 2017: 3.1×FY 2018: 7.6×FY 2019: 7.4×FY 2020: 6.5×FY 2021: 15.3×FY 2022: 9.2×
FY 2013 5y median 7.6× FY 2022
FCF Yield -18.4%
FY 2013: -6.1%FY 2014: -5.1%FY 2015: -50.3%FY 2016: -84.0%FY 2017: 1.0%FY 2018: -25.6%FY 2019: -12.0%FY 2020: -7.0%FY 2021: -15.1%FY 2022: -18.4%
FY 2013 5y median -15.1% FY 2022

Profitability

Gross Margin 99.8%
FY 2013: -78.6%FY 2014: -30.7%FY 2015: -144.9%FY 2016: -190.6%FY 2017: -21.0%FY 2018: -223.1%FY 2019: -39.2%FY 2020: 13.4%FY 2021: 100.0%FY 2022: 99.8%
FY 2013 5y median 13.4% FY 2022
Operating Margin -203.1%
FY 2013: -119.4%FY 2014: -63.7%FY 2015: -206.4%FY 2016: -269.8%FY 2017: -51.1%FY 2018: -298.2%FY 2019: -112.0%FY 2020: -102.4%FY 2021: -179.0%FY 2022: -203.1%
FY 2013 5y median -179.0% FY 2022
Net Margin -204.9%
FY 2013: -119.1%FY 2014: -71.0%FY 2015: -239.4%FY 2016: -322.3%FY 2017: -83.2%FY 2018: -311.9%FY 2019: -148.4%FY 2020: -50.4%FY 2021: -199.4%FY 2022: -204.9%
FY 2013 5y median -199.4% FY 2022
ROE -143.1%
FY 2013: -94.3%FY 2014: -173.0%FY 2015: 177.0%FY 2016: 102.5%FY 2017: 536.5%FY 2018: -1405.7%FY 2019: 160.4%FY 2020: -74.4%FY 2021: -42.8%FY 2022: -143.1%
FY 2013 5y median -74.4% FY 2022
ROIC -95.6%
FY 2013: -49.5%FY 2014: -18.3%FY 2015: -50.2%FY 2016: -93.7%FY 2017: -25.6%FY 2018: -74.9%FY 2019: -57.2%FY 2020: -56.9%FY 2021: -29.2%FY 2022: -95.6%
FY 2013 5y median -57.2% FY 2022
ROA -63.9%
FY 2013: -43.2%FY 2014: -19.4%FY 2015: -50.0%FY 2016: -78.8%FY 2017: -32.6%FY 2018: -56.8%FY 2019: -51.8%FY 2020: -18.8%FY 2021: -26.5%FY 2022: -63.9%
FY 2013 5y median -51.8% FY 2022

Growth (YoY)

Revenue 55.7%
FY 2013: 68.6%FY 2014: 42.8%FY 2015: -29.9%FY 2016: -19.0%FY 2017: 137.4%FY 2018: -53.4%FY 2019: 52.9%FY 2020: 60.8%FY 2021: -47.2%FY 2022: 55.7%
FY 2013 FY 2022
Operating Income -76.6%
FY 2013: 2.0%FY 2014: 23.9%FY 2015: -127.4%FY 2016: -6.0%FY 2017: 55.0%FY 2018: -172.1%FY 2019: 42.6%FY 2020: -47.0%FY 2021: 7.7%FY 2022: -76.6%
FY 2013 FY 2022
EPS (diluted) 18.7%
FY 2013: 4.6%FY 2014: 14.5%FY 2015: -132.4%FY 2016: -9.1%FY 2017: 45.6%FY 2018: -22.4%FY 2019: 31.7%FY 2020: 53.7%FY 2021: -184.6%FY 2022: 18.7%
FY 2013 FY 2022
Free Cash Flow 0.0%
FY 2013: 3.5%FY 2014: -1.4%FY 2015: -115.0%FY 2016: -10.7%FY 2017: 104.4%FY 2018: -2729.3%FY 2019: 46.9%FY 2020: 12.8%FY 2021: -190.6%FY 2022: 0.0%
FY 2013 FY 2022

Financial Health

Current Ratio 2.3×
FY 2013: 6.7×FY 2014: 7.8×FY 2015: 4.1×FY 2016: 3.2×FY 2017: 4.8×FY 2018: 3.7×FY 2019: 2.3×FY 2020: 2.4×FY 2021: 4.7×FY 2022: 2.3×
FY 2013 5y median 2.4× FY 2022
Quick Ratio 2.5×
FY 2013: 6.6×FY 2014: 7.7×FY 2015: 4.0×FY 2016: 3.1×FY 2017: 4.8×FY 2018: 4.0×FY 2019: 2.7×FY 2020: 2.7×FY 2021: 5.0×FY 2022: 2.5×
FY 2013 5y median 2.7× FY 2022
Debt / Equity 0.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: -1.2×FY 2016: 0.0×FY 2017: -0.1×FY 2018: 0.2×FY 2019: -0.4×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.1×
FY 2013 5y median 0.1× FY 2022
Net Debt / EBITDA 1.2×
FY 2013: 2.0×FY 2014: 5.0×FY 2015: 1.2×FY 2016: 1.3×FY 2017: 4.8×FY 2018: 1.7×FY 2019: 1.8×FY 2020: -102×FY 2021: 3.5×FY 2022: 1.2×
FY 2013 5y median 1.7× FY 2022
Interest Coverage -53.0×
FY 2013: 0.0×FY 2014: -10.0×FY 2015: -6.2×FY 2016: 0.0×FY 2017: -3.5×FY 2018: -15.0×FY 2019: -5.4×FY 2020: -5.8×FY 2021: -9.5×FY 2022: -53.0×
FY 2013 5y median -9.5× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31